Medicare Part D is changing, and dermatology patients are feeling it first. As plans redesign their formularies in response to new negotiation rules, coverage for advanced dermatologic therapies is shifting — sometimes in ways that leave stable patients scrambling for alternatives.
In this piece from DCAN's blog series in Medscape Dermatology, we walk through what the changes mean for patients with chronic skin conditions, what clinicians should watch for at the start of each plan year, and where the coalition sees opportunities for policymakers to protect access while pursuing affordability.
This is sample article copy — replace it with the full text or a summary and link from the site admin.
